Functional chewing gum

01Overview and value chain

Markers: [EC: EU Reg (EC) 1924/2006 nutrition & health claims plus (EC) 1333/2008 food-additive authorisation for gum-base substances | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)]

Functional chewing gum is a chewable delivery format that carries an active ingredient across the oral mucosa rather than through the gut, packaging caffeine, L-theanine, melatonin, xylitol, hydroxyapatite or probiotics into a stick or pellet consumers already chew for taste. Neuro Gum delivers 20-40mg of caffeine plus L-theanine per piece and carries a 4.8-out-of-5 rating across more than 5,000 reviews; its Sleep & Recharge line offers 1mg or 5mg melatonin strengths. Brew Chew’s whitening gum uses a three-ingredient active blend (xylitol, hydroxyapatite, calcium carbonate) in an all-natural, plastic-free chicle base. The category sits downstream of a specialised gum-base supply chain: Cafosa Gum is named among the “Top 10 Companies in the Natural Gum Base Industry” in a 2025 market report, and Fertin Pharma runs a contract- manufacturing platform that turns gum into a chewable format for nutraceutical and wellness brands.

The key directions of functional chewing gum are:

1. Cognitive and energy gum (Nootropic Gum): caffeine plus L-theanine delivered through the oral mucosa for faster onset than a swallowed capsule (Neuro Gum’s Energy & Focus line, 20-40mg caffeine per piece).
2. Sleep and recovery gum (Sleep Meltaways): melatonin-dosed meltaway mints at 1mg (regular) or 5mg (extra-strength) sold as a bedtime ritual (Neuro Brands' Sleep & Recharge).
3. Oral-care and whitening gum (Whitening Gum): xylitol, hydroxyapatite and calcium carbonate combined in a sugar-free, plastic-free chicle base for surface-stain defence and enamel support (Brew Chew).
4. Contract-manufactured nutraceutical gum (Gum-as-a-Delivery-Platform): B2B oral- delivery development and manufacturing for vitamin, mineral and probiotic brands, built on specialty gum-base ingredient supply (Fertin Pharma, Cafosa Gum).

Sectoral value chain

[gum-base compounding] ──> [active formulation] ──> [extrusion / sheeting] ──> [coating / dosing]
                                     │
                            (active-dose uniformity)
                                     │
                                     ▼
[retail distribution] <─── [packaging + stability QA] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• Gum-base formulation (Gum-Base Formulation): the elastomer/resin/wax system — natural chicle or synthetic — that carries flavour and actives and defines chew texture and active-release rate.
• Oral-mucosal active delivery (Oral-Mucosal Active Delivery): absorption of an active ingredient across the buccal mucosa during chewing, giving a faster onset than a swallowed capsule for actives like caffeine and melatonin.
• Active-dose uniformity (Active-Dose Uniformity): formulation and coating control that keeps caffeine, melatonin or probiotic dose consistent piece-to-piece, the quality-control anchor for any health or performance claim.

02US

The United States leads the direct-to-consumer functional-gum category, with two distinct product angles: cognitive/sleep nootropic gum and natural whitening gum.

nootropic energy and sleep gum, whitening gum, DTC subscription

• Neuro Brands (Neuro Gum): a direct-to-consumer nootropic gum and mints brand whose Energy & Focus gum packs 20-40mg of natural caffeine and L-theanine per piece (4.8-out-of-5 rating, 5,000+ reviews) and whose Sleep & Recharge meltaway mints carry melatonin at 1mg or 5mg strength, sold in 54- to 144-piece packs on a subscribe-and-save model.
• Brew Chew: an all-natural, sugar-free, plastic-free teeth-whitening gum built on a three-ingredient active system (xylitol, hydroxyapatite, calcium carbonate) in a chicle base, launched in 2025 and marketed as a routine-friendly whitening habit rather than a treatment.
• DTC subscription model: both brands sell primarily direct-to-consumer with variety packs and subscription pricing, positioning functional gum as a habitual, replenishable format rather than an occasional purchase.

03CN

China’s functional-gum market is characterised in 2026 market-outlook coverage as shifting from basic breath-freshening toward oral-health, nutrition, alertness and mood-regulation formats, though no single commercial originator was confirmed as a named producer in this pass.

breath-to-wellness repositioning, xylitol/probiotic actives, no confirmed originator

• Category repositioning: Chinese industry-research coverage describes functional chewing gum as a “typical representative” of the shift from traditional snack food to health-oriented consumption, extending beyond fresh-breath into oral-health maintenance, nutrition supplementation, mental alertness and mood regulation.
• Common actives cited: the same market coverage lists xylitol, probiotics, calcium, B vitamins, caffeine, L-theanine and palatinose as the active ingredients used to support cavity prevention, anxiety relief and related claims.
• No confirmed commercial anchor: searches surfaced generic e-commerce listings for xylitol/breath-freshening gum rather than a company-specific product launch or business update, so China is held qualitative rather than tabled with a named producer.

04EU

Europe supplies the enabling layer of the industry — a specialised gum-base ingredient maker and a contract manufacturer that turns gum into a delivery platform for other brands’ nutraceutical claims.

gum-base ingredient supply, contract-manufactured nutraceutical gum, oral delivery platforms

• Cafosa Gum (Spain): a gum-base ingredient supplier named among the “Top 10 Companies in the Natural Gum Base Industry” in a 2025 market report, supplying the elastomer/resin base that functional-gum brands formulate actives into.
• Fertin Pharma (Denmark): an oral-delivery-systems specialist that develops, manufactures and launches chewable nutraceutical and wellness products in partnership with consumer brands, positioning gum as a delivery platform rather than a confectionery product in its own right.
• B2B platform model: the EU side of the industry is structured around supplying and manufacturing for brand owners rather than owning consumer-facing functional-gum brands directly, contrasting with the US DTC pattern.

05Leading companies and research institutes

06Tech stack and innovations

The functional-gum stack rests on gum-base formulation, active-ingredient dosing and dose-uniformity QC, each layer protecting the health or performance claim the product is sold on.

1. Gum-base formulation (Gum-Base Formulation):
   • the elastomer/resin/wax system — natural chicle (Brew Chew) or a formulated synthetic base — is compounded to a target chew texture and active-release profile before any active is added.
   • specialty gum-base suppliers such as Cafosa Gum sell this layer as a raw-material platform to brand owners rather than finished gum.
2. Oral-mucosal active delivery (Oral-Mucosal Active Delivery):
   • caffeine, L-theanine and melatonin absorb across the buccal mucosa during chewing, giving a faster onset than a swallowed capsule — the core value proposition of nootropic and sleep gum.
   • whitening actives (hydroxyapatite, calcium carbonate) instead act mechanically and topically at the tooth surface during chewing.
3. Active-dose uniformity (Active-Dose Uniformity):
   • formulation and coating steps are controlled so caffeine, melatonin or whitening- active dose stays consistent piece-to-piece, the quality-control anchor behind any performance or health claim.
   • contract manufacturers like Fertin Pharma sell dose-uniformity and regulatory know-how as part of their oral-delivery platform to brands that do not run their own gum-manufacturing line.

07Value chains and production pipelines

Industrial pipeline of a functional chewing gum (US/EU food GMP, ISO 22000)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Gum-base compounding    │ ───> │ 2. Active formulation      │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Coating & dose-finishing│ <─── │ 3. Extrusion & sheeting    │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Packaging & stability QA│ ───> │ 6. Retail distribution     │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Gum-base compounding

Elastomer, resin, wax and softener are melted and blended into a chewable base with a target chew texture, sourced from a specialty gum-base supplier or compounded in-house.

Stage 2: Active formulation

Caffeine, L-theanine, melatonin, xylitol, hydroxyapatite or probiotic actives are dosed into or onto the gum base at a target concentration per piece (for example, 20-40mg caffeine or 1-5mg melatonin).

Stage 3: Extrusion and sheeting

The kneaded, active-loaded mass is rolled and sheeted, then cut into individual gum pieces or pellets at a controlled unit weight.

Stage 4: Coating and dose-finishing

A sugar-free candy-coating or pellet-coating step locks in flavour and confirms active-dose uniformity across pieces before release.

Stage 5: Packaging and stability QA

Moisture- and oxygen-barrier packaging protects heat- and humidity-sensitive actives (melatonin, probiotics) through ambient distribution, with stability testing backing shelf-life claims.

Stage 6: Retail distribution

Product reaches direct-to-consumer subscription channels or retail shelf, sold as a habitual, replenishable format rather than a one-time treatment.